Received May 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y014868 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AEs; patient received improperly stored vaccine; This spontaneous report was received from a certified medical assistant (CMA) on 28-APR-2025 and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions were not reported, and concomitant therapies were not reported. 24-APR-2025, the patient was vaccinated with an improper stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y014868, expiration date: 03-SEP-2026), dose/frequency was reported as 1 dose, and sterile diluent (lot #, dose, route o administration not reported) for prophylaxis (Product storage error). The administered dose of the vaccine experienced a temperature excursion 5.5 Fahrenheit up to 14.4 Fahrenheit for 40 minutes and 14.5 Fahrenheit up to 46.4 Fahrenheit for 10 minutes, with no previous temperature excursion reported. No adverse vent reported.